載入...
Real-Life Experience of a Brief Arsenic Trioxide-Based Consolidation Chemotherapy in the Management of Acute Promyelocytic Leukemia: Favorable Outcomes With Limited Anthracycline Exposure and Shorter Consolidation Therapy
Arsenic trioxide (ATO)-based consolidation chemotherapy can be effective in patients with high-risk acute promyelocytic leukemia (APL) and might reduce anthracycline-related toxicity. We report a retrospective analysis of 63 patients with APL given 1 cycle of ATO-based consolidation chemotherapy. Th...
Na minha lista:
| 發表在: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4409502/ https://ncbi.nlm.nih.gov/pubmed/25499624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.11.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|